Study Links Inherited Mutations to Okur-Chung Neurodevelopment Syndrome

PHOENIX, AZ  ­– August 16, 2023 — Okur-Chung neurodevelopmental syndrome (OCNDS) has long perplexed the medical community with its varied manifestations and genetic origins. A recent study, led by researchers at the Translational Genomics Research Institute (TGen), part of City of Hope, has revealed insights into the hereditary aspects of OCNDS, shedding light on the genetic underpinnings and potential implications for affected families. Continue reading

GT Medical Technologies Awarded the Arizona Bioscience Company of the Year for Disrupting the Status Quo in Brain Tumor Treatment

TEMPE, Ariz., Aug. 15, 2023 /PRNewswire/ — The Arizona Bioindustry Association, Inc. (AZBio) announced that GT Medical Technologies, Inc. (GT MedTech) will be honored as the Arizona Bioscience Company of the Year at the 2023 AZBio Awards and 20th Anniversary Celebration on Sept. 27 in Phoenix, Arizona.Continue reading

C-Path’s Duchenne Regulatory Science Consortium and Duchenne Data Foundation Announce Collaboration to Advance Solutions for Duchenne Muscular Dystrophy

TUCSON, Ariz. and VEENENDAAL, Netherlands, August 9, 2023 — Critical Path Institute’s (C-Path) Duchenne Regulatory Science Consortium (D-RSC) and the Duchenne Data Foundation (DDF) are excited to announce a joint collaboration aimed at advancing research and improving healthcare for individuals with Duchenne muscular dystrophy (DMD) and other dystrophinopathies (conditions linked to mutations in the DMD gene).Continue reading